日韩人妻无码一本二本三本,国产免费不卡av在线播放,國产一二三内射在线看片

產(chǎn)品展示 / PRODUCTS
當(dāng)前位置：首頁 > 產(chǎn)品展示 > 進(jìn)口抗體 > 25羥基維生素D試劑盒 > Mouse/Rat FGF-23 ELISA Kit

名稱	Mouse/Rat FGF-23 ELISA Kit
型號
更新時(shí)間	2023-09-25
特點(diǎn)	Mouse/Rat FGF-23 (C-Term)ELISA Kit is intended for research use only in the quantitative determination of Mouse FGF-23 levels in serum, plasma or cell culture media.}

詳細(xì)內(nèi)容

一.產(chǎn)品名稱：

通用名稱：大/小鼠成纖維細(xì)胞生長因子23 ELISA試劑盒

英文名稱：Mouse/Rat FGF-23 ELISA Kit

二.Mouse FGF-23 ELISA介紹：

Mouse/Rat FGF-23 ELISA Kit is intended for research use only in the quantitative determination of Mouse FGF-23 levels in serum, plasma or cell culture media. This assay is also useful in the determination of Rat FGF-23 levels.

Fibroblast growth factor 23 (FGF-23) is a recently discovered, novel member of a large family of related proteins. Its gene encodes a 251 amino acid protein. The amino-terminal portion of FGF-23 (aa 1-24) is hydrophobic and is likely to serve as a signal peptide allowing its secretion into the blood circulation. Its carboxyl-terminal portion (aa 180-251) shares only limited amino acid homology with other members of the FGF family of proteins.

Renal phosphate wasting disorders leading to hypophosphatemia are among the causes of defective mineralization of bone and growth plate development. Autosomal dominant hypophosphatemic rickets (ADHR), a rare genetic disorder, results from one of several different FGF-23 mutations that make the protein resistant to proteolytic cleavage. Furthermore, tumors that cause oncogenic osteomalacia (OOM) have been shown to overexpress FGF-23 mRNA making it likely that elevated concentrations of FGF-23 in the blood are the cause of renal phosphate wasting. Consistent with this conclusion, the administration of recombinant FGF-23 to rodents was shown to increase urinary excretion of phosphate thus leading to hypophosphatemia and osteomalacia/rickets. Recent studies with chronic kidney disease (CKD) patients have shown FGF-23 to be an early predictor of abnormal renal tubular function, bone mineralization, disease progression and over-all mortality risk.

Taken together, all currently available data suggest that the measurement of FGF-23 levels may provide an important diagnostic tool for the evaluation of hypophosphatemic and hyperphosphatemic disorders.

如需了解更多產(chǎn)品，請北京科瑞美公司。